奥翔药业：上半年归母净利润1.69亿元，同比下降5.83%

Group 1 - The company reported a revenue of 482 million yuan for the first half of the year, representing a year-on-year decrease of 2.14% [1] - The net profit attributable to shareholders was 169 million yuan, showing a year-on-year decline of 5.83% [1] - The basic earnings per share stood at 0.2 yuan per share [1]